Frequent urination without prior evaluation
A symptom, not a diagnosis. Frequent urination may stem from urinary tract infection, diabetes mellitus, benign prostatic hyperplasia, neurological disease, or excess caffeine and fluid intake. Before any bladder medication, the patient needs a bladder ultrasound with post-void residual, urinalysis and a 3-day voiding diary.
ICD-10 R355 drugs
Also known as: Pollakiuria, Increased urinary frequency
Marketing claims without evidence base
The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.
- FFesoterodineNot recommended · Muscarinic receptor antagonist for overactive bladderFesoterodine is for overactive bladder, not a symptomatic drug for frequent toilet visits. Increased urinary frequency is a symptom that may mean urinary tract infection, diabetes mellitus, benign prostatic hyperplasia, neurological disease, or excess caffeine and fluid intake. Prescribing a muscarinic blocker without a bladder ultrasound and urinalysis can mask UTI, bladder cancer or BPH outlet obstruction. In older men with untreated BPH, fesoterodine raises the risk of acute urinary retention (AEMPS warning). If this drug was prescribed without a bladder ultrasound, urinalysis, or discussion of behavioural therapy, consider seeking a second opinion.
- FPropiverineNot recommended · Muscarinic blocker with additional calcium channel blockadePropiverine is marketed as a drug for «frequent toilet visits» without proper diagnostic workup. Increased urinary frequency is a symptom that may mean UTI, diabetes mellitus, BPH, neurological disease, or excess caffeine and fluid intake. Before any muscarinic blocker, the patient needs a bladder ultrasound with post-void residual, urinalysis and a 3-day voiding diary. In men over 50 with untreated BPH, the drug raises the risk of acute urinary retention. If propiverine was prescribed without a bladder ultrasound or urinalysis, consider seeking a second opinion.
- FSolifenacinNot recommended · Antimuscarinic for overactive bladderSolifenacin is heavily marketed as a drug for «frequent toilet visits». Increased urinary frequency is a symptom that may mean UTI, diabetes mellitus, BPH, neurological disease, or excess caffeine and fluid intake. Per Beers Criteria 2023 (AGS) all muscarinic blockers fall into the «avoid in older adults» category, especially with cognitive impairment. The Gray et al. cohort study (JAMA Intern Med 2015) showed cumulative anticholinergic exposure over 3 years is linked to a 54% increase in dementia risk. If solifenacin was prescribed without a bladder ultrasound, urinalysis, or discussion of behavioural therapy, consider seeking a second opinion.
- FTolterodineNot recommended · Muscarinic receptor antagonist for overactive bladderTolterodine is for overactive bladder, not a symptomatic drug for frequent toilet visits. Increased urinary frequency can mean UTI, diabetes mellitus, BPH, neurological disease, or excess caffeine and fluid intake. In older patients with UTI, a muscarinic blocker masks the infection and delays antibacterial therapy. Per Beers Criteria 2023 (AGS) all muscarinic blockers fall into the «avoid in older adults» category, especially with cognitive impairment. If tolterodine was prescribed without a bladder ultrasound, urinalysis, or discussion of behavioural therapy, consider seeking a second opinion.
- FTrospiumNot recommended · Quaternary ammonium muscarinic blocker for overactive bladderTrospium is prescribed for «frequent toilet visits» without proper diagnostic workup, especially in Russia under the Spasmex brand. Increased urinary frequency is a symptom that may mean UTI, diabetes mellitus, BPH, neurological disease, or excess caffeine and fluid intake. Before any muscarinic blocker, the patient needs a bladder ultrasound with post-void residual, urinalysis and a 3-day voiding diary. In men over 50 with untreated BPH, trospium raises the risk of acute urinary retention. If trospium was prescribed without a bladder ultrasound or urinalysis, consider seeking a second opinion.
How to read tiers A–F
Evidence tiers belong to the drug-indication pair, not to the drug as a whole: the same substance can be A for one condition and F for another.
- AStrong evidence – first or second line in international guidelines
- BRecommended in selected cases
- CStudy data contradict each other
- DBenefit not proven, no documented harm
- FDocumented harm, or risk without benefit